Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA1869 | IKK16 | 2.0 | uM | 1 | TRAIL | 17.0 | 59 | ||||
| N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | TRAIL | 17.0 | 61 | ||||
| N2759 | IKK16 | 2.0 | uM | 1 | TRAIL | 17.0 | 69 | ||||
| RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | TRAIL | 17.0 | 53 | ||||
| RA1931 | IKK16 | 2.0 | uM | 1 | TRAIL | 16.0 | 71 | ||||
| N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | TRAIL | 16.0 | 58 | ||||
| N2586 | IKK16 | 2.0 | uM | 1 | TRAIL | 19.0 | 84 | ||||
| RA1869 | Tofacitinib | 0.3 | uM | 1 | TRAIL | 17.0 | 55 | ||||
| RA1869 | 1 | TRAIL | 17.0 | 56 | |||||||
| N2759 | Tofacitinib | 0.3 | uM | 1 | TRAIL | 19.0 | 55 | ||||
| N2759 | 1 | TRAIL | 19.0 | 51 | |||||||
| RA1931 | Tofacitinib | 0.3 | uM | 1 | TRAIL | 21.0 | 46 | ||||
| RA1931 | 1 | TRAIL | 20.5 | 68 | |||||||
| N2586 | Tofacitinib | 0.3 | uM | 1 | TRAIL | 22.5 | 42 | ||||
| N2586 | 1 | TRAIL | 19.0 | 66 | |||||||
| 0 | TRAIL | 20.0 | 53 | ||||||||
| 0 | TRAIL | 23.0 | 63 | ||||||||
| 0 | TRAIL | 21.0 | 63 | ||||||||
| 0 | TRAIL | 37.0 | 55 | ||||||||
| 0 | TRAIL | 37.0 | 44 | ||||||||
| 0 | TRAIL | 30.5 | 36 | ||||||||
| RA2159 | 2 | TRAIL | 28.0 | 68 | |||||||
| N2645 | 2 | TRAIL | 29.0 | 62 | |||||||
| RA2708 | 2 | TRAIL | 33.0 | 65 | |||||||
| RA2159 | JNK-IN-8 | 3.0 | uM | 2 | TRAIL | 29.5 | 76 |